Our Company

A patient walks out of her cataract surgery, accompanied by her nurse
  • Our Company

We are reimagining medicine

We reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.

The Novartis Purpose and Vision

Our purpose is to reimagine medicine to improve and extend people`s lives.

Our vision is to be a trusted leader in changing the practice of medicine.

Our Business

Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our divisions - Innovative Medicines and Sandoz - are supported by functional organizations with global scale. Research and development (R&D) is at the core of our company and central to the Novartis strategy.

  • Innovative Medicines

    Made up of two business units – Novartis Pharmaceuticals and Novartis Oncology – our Innovative Medicines Division commercializes innovative patented medicines to enhance health outcomes for patients and healthcare professionals.

  • Sandoz

    Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.

  • The Novartis Institutes for BioMedical Research (NIBR)

    NIBR is the innovation engine of Novartis and focuses on discovering new drugs that can change the practice of medicine.

Novartis Global Product Portfolio and Clinical Pipeline
Novartis Corporate History

Novartis was created in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis and its predecessor companies trace roots back more than 250 years, with a rich history of developing innovative products.

Awards and Recognition

Novartis is honored to receive numerous awards for progress in research and development, our working environment, and our corporate responsibility activities.

  • Fortune's Most Admired Pharmaceutical Companies 2019

    Novartis ranks #4 in Fortune Magazine’s Most Admired Companies Pharmaceutical Industry list.